As the company name suggests, Cancer Genetics, Inc. is one of the companies that focus its resources in the field of oncology. The company is headquartered in Rutherford, New Jersey and is traded publicly on the NASDAQ, using the ticker symbol CGIX.
It was in 1999 that the company started its operations. Today, it is now ranked as one of the leaders in in providing the world with personalized medicine. Through the diagnostic products and services offered by the company, healthcare providers are able to provide precise medication to patients suffering from cancer. The offerings of the company not only promote treatment efficacy, it also transforms the industry of patient management specific to cancer and overall, reduce the healthcare cost in addressing the disease.
It was world-renowned cytogeneticist Dr. R.S.K. Chaganti, who started the company. To continuously meet the critical needs in the ordeal in oncology, Cancer Genetics has forged a strong relationship with Mayo Clinic, Oncospire Genomics.